In vitro pharmacological purging of human bone marrow is enhanced by the use of lonidamine
- 30 April 1989
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 50 (2) , 210-219
- https://doi.org/10.1016/0014-4800(89)90032-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complementLeukemia Research, 1987
- Induction of stress proteins by lonidamine in human and murine melanoma cellsExperimental and Molecular Pathology, 1986
- Effect of lonidamine on protein synthesis in neoplastic cellsExperimental and Molecular Pathology, 1985
- Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complementBlood, 1985
- Inhibition of the recovery from potentially lethal damage by lonidamineBritish Journal of Cancer, 1984
- Autologous bone marrow transplantation in hematological malignanciesEuropean Journal of Cancer and Clinical Oncology, 1984
- Lonidamine plus Adriamycin versus Adriamycin Alone in the Adjuvant Treatment of Recurrent Papillary Carcinomas of the Urinary BladderOncology, 1984
- Action of the antitumor and antispermatogenic agent lonidamine on electron transport in ehrlich ascites tumor mitochondriaArchives of Biochemistry and Biophysics, 1983
- Human granulocytes generated in continuous bone marrow culture are physiologically normalBlood, 1981
- The Spearman Estimator for Serial Dilution AssaysPublished by JSTOR ,1961